- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02193464
Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk (EPICODE)
January 8, 2021 updated by: Eun Soo Kim, MD, PhD, Kyungpook National University Hospital
Observational Study Using Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk, Southeastern Area of Korea
The purpose of this study is to investigate the incidence and natural course of inflammatory bowel disease in the southeastern area of Korea.
Study Overview
Status
Recruiting
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Eun Soo Kim, MD. PhD
- Phone Number: +82-53-250-7088
- Email: dandy813@hanmail.net
Study Locations
-
-
-
Daegu, Korea, Republic of, 700-712
- Recruiting
- Keimyung University Dongsan Medical Center
-
Principal Investigator:
- Eun Soo Kim, MD, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
All patients with inflammatory bowel disease from primary, secondary, and tertiary hospital in Daegu-Gyeongbuk province of Korea.
Description
Inclusion Criteria:
- Clinical diagnosis of inflammatory bowel disease including Crohn's disease and ulcerative colitis
- Followed up for at least 6 months for the correct diagnosis
Exclusion Criteria:
- Patients who do not live in Daegu-Gyeongbuk province
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
inflammatory bowel disease
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
All newly diagnosed cases
Time Frame: one year
|
In one year, all inflammatory bowel disease including Crohn's disease and ulcerative colitis which is newly diagnosed in Daegu-Gyeongbuk province of Korea is recorded.
|
one year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
All operation cases
Time Frame: one year
|
For one year, all patients who have surgical managements for IBD are counted.
|
one year
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
All cases of disease relapse
Time Frame: one year
|
For one year, all patients who have disease worsening are counted.
|
one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 1, 2014
Primary Completion (ANTICIPATED)
December 1, 2025
Study Completion (ANTICIPATED)
December 1, 2026
Study Registration Dates
First Submitted
July 16, 2014
First Submitted That Met QC Criteria
July 16, 2014
First Posted (ESTIMATE)
July 17, 2014
Study Record Updates
Last Update Posted (ACTUAL)
January 12, 2021
Last Update Submitted That Met QC Criteria
January 8, 2021
Last Verified
January 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EPICODE
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Idiopathic Chronic Inflammatory Bowel Disease
-
University Hospital, MontpellierRennes University Hospital - CHU PontchaillouUnknownChronic Inflammatory Bowel DiseaseFrance
-
EPSTEIN JonathanNot yet recruitingChronic Inflammatory Bowel Diseases
-
Groupe Hospitalier Paris Saint JosephCompletedHemorrhoids | Chronic Inflammatory Bowel DiseaseFrance
-
NYU Langone HealthWithdrawnInflammatory Bowel DiseaseUnited States
-
Medtronic - MITGCompletedCrohn's Disease | Chronic Inflammatory Small Bowel DiseaseIsrael, Spain, Italy
-
Istituto Clinico HumanitasUnknownInflammatory Bowel Disease | Chronic FatigueItaly
-
Medtronic - MITGCompletedChronic Inflammatory Small Bowel DiseaseIsrael
-
Ced Service GmbHPfizerTerminatedColitis, Ulcerative | Bowel Disease | Bowel Diseases, Inflammatory | Biologics | Chronic Inflammatory Small Bowel Disease | Tofacitiniib | CEDGermany
-
Centre Hospitalier Universitaire, AmiensFunding from DGOS (PHRC IR 2013 and PRME)CompletedPediatric Inflammatory Bowel DiseaseFrance
-
University of British ColumbiaCompletedInflammatory Bowel Disease 11Canada